2018 annual financial data

XTL Biopharmaceuticals Ltd. 2018 Operating margin

XTL Biopharmaceuticals Ltd. 2018 operating margin with verified reported values.

Direct answer

Operating margin was -1,525%.

Operating income was -793,000 USD and net income was 2,986,000 USD.
Operating cash flow was -816,000 USD.

Get free XTL Biopharmaceuticals Ltd. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
52,000 USD
Operating income
-793,000 USD
Net income
2,986,000 USD
Operating cash flow
-816,000 USD